+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HLA Typing for Transplant Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • October 2024
  • Region: Global
  • Allied Market Research
  • ID: 6053968

HLA Typing for Transplant Market

The HLA typing for transplant market was valued at $0.9 billion in 2023 and is projected to reach $1.7 billion by 2033, growing at a CAGR of 6.6% from 2024 to 2033.

Human leukocyte antigen (HLA) typing for transplant is an analysis procedure that determines the compatibility between donor and recipient for organ transplant. The proteins transcribed by HLA genes play a critical role in the immune system of humans. The most common forms of organ transplants that involve HLA typing are stem cell and solid organ transplants. A high percentage of HLA matches is critical to ensure that donor or recipient cells do not attack the other post-transplantation.

Rise in the prevalence of chronic conditions such as liver cirrhosis and kidney diseases has fueled organ transplant procedures globally, driving the HLA typing for transplant market. In addition, the availability of effective reimbursement policies for HLA typing and organ transplantation has enhanced their accessibility for patients, augmenting the development of the market. An emerging trend poised to dominate the HLA typing for transplant market is the deployment of third-generation sequencing techniques such as single-molecule real-time sequencing and Oxford Nanopore. These techniques improve accuracy, reduce ambiguity, and enhance the assessment of compatibility for transplantation.

However, the high expenditure associated with HLA typing and organ transplantations deters several patients from opting for such treatments, restraining the development of the market. Moreover, the scarcity of available organs reduces the opportunities for transplantations, which impacts the overall demand for HLA typing and hampers the market growth.

On the contrary, rise in awareness regarding the necessity of organ donation has upsurged the number of individuals signing up for it post their demise. For instance, a novel annual record was set in the U.S. in 2023 owing to the availability of more than 16,000 deceased organ donors. Therefore, rise in the number of readily available organs for transplant is projected to boost HLA typing for testing the compatibility, opening new avenues for the market.

Segment Review

The HLA typing for transplant market is segmented into technology, product, application, type, end user, and region. On the basis of technology, the market is bifurcated into molecular assay and non-molecular assay. Depending on product, it is divided into instruments, reagents & consumables, and software & services. According to application, it is bifurcated into diagnostic and research. As per type, it is classified into organ transplant and tissue. By end user, it is categorized into independent reference laboratories, hospital & transplant center, and other. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technology, the molecular assay segment held a high share of the market in 2023.

Depending on product, the reagents & consumables segment acquired a high stake in the market in 2023.

According to application, the diagnostic segment dominated the market in 2023.

As per type, the organ transplant segment was the highest shareholder in 2023.

By end user, the independent reference laboratories segment accounted for a high share of the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global HLA typing for transplant market include Luminex Corporation, Pacific Biosciences of California, Inc., Abbott Laboratories, Bio-Rad Laboratories, BioReference Laboratories, Qiagen N.V, F. Hoffmann-La Roche Ltd., Illumina Inc., Fujirebio, and BAG Diagnostic GmbH. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Technology

  • Molecular Assay
  • Non-Molecular Assay

By Product

  • Instruments
  • Reagents Consumables
  • Software Services

By Application

  • Diagnostic
  • Research

By Type

  • Organ Transplant
  • Tissue

By End User

  • Independent Reference Laboratories
  • Hospital Transplant Center
  • Other

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Luminex Corporation
  • Pacific Biosciences of California, Inc
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • BioReference Laboratories
  • Qiagen N.V
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Fujirebio
  • BAG Diagnostic GmbH

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: HLA TYPING FOR TRANSPLANT MARKET, BY TECHNOLOGY
4.1. Market Overview
4.1.1 Market Size and Forecast, By Technology
4.2. Molecular Assay
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Non-Molecular Assay
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: HLA TYPING FOR TRANSPLANT MARKET, BY PRODUCT
5.1. Market Overview
5.1.1 Market Size and Forecast, By Product
5.2. Instruments
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Reagents Consumables
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Software Services
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: HLA TYPING FOR TRANSPLANT MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Diagnostic
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Research
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
CHAPTER 7: HLA TYPING FOR TRANSPLANT MARKET, BY TYPE
7.1. Market Overview
7.1.1 Market Size and Forecast, By Type
7.2. Organ Transplant
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Tissue
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
CHAPTER 8: HLA TYPING FOR TRANSPLANT MARKET, BY END USER
8.1. Market Overview
8.1.1 Market Size and Forecast, By End User
8.2. Independent Reference Laboratories
8.2.1. Key Market Trends, Growth Factors and Opportunities
8.2.2. Market Size and Forecast, By Region
8.2.3. Market Share Analysis, By Country
8.3. Hospital Transplant Center
8.3.1. Key Market Trends, Growth Factors and Opportunities
8.3.2. Market Size and Forecast, By Region
8.3.3. Market Share Analysis, By Country
8.4. Other
8.4.1. Key Market Trends, Growth Factors and Opportunities
8.4.2. Market Size and Forecast, By Region
8.4.3. Market Share Analysis, By Country
CHAPTER 9: HLA TYPING FOR TRANSPLANT MARKET, BY REGION
9.1. Market Overview
9.1.1 Market Size and Forecast, By Region
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. Market Size and Forecast, By Technology
9.2.3. Market Size and Forecast, By Product
9.2.4. Market Size and Forecast, By Application
9.2.5. Market Size and Forecast, By Type
9.2.6. Market Size and Forecast, By End User
9.2.7. Market Size and Forecast, By Country
9.2.8. U.S. HLA Typing for Transplant Market
9.2.8.1. Market Size and Forecast, By Technology
9.2.8.2. Market Size and Forecast, By Product
9.2.8.3. Market Size and Forecast, By Application
9.2.8.4. Market Size and Forecast, By Type
9.2.8.5. Market Size and Forecast, By End User
9.2.9. Canada HLA Typing for Transplant Market
9.2.9.1. Market Size and Forecast, By Technology
9.2.9.2. Market Size and Forecast, By Product
9.2.9.3. Market Size and Forecast, By Application
9.2.9.4. Market Size and Forecast, By Type
9.2.9.5. Market Size and Forecast, By End User
9.2.10. Mexico HLA Typing for Transplant Market
9.2.10.1. Market Size and Forecast, By Technology
9.2.10.2. Market Size and Forecast, By Product
9.2.10.3. Market Size and Forecast, By Application
9.2.10.4. Market Size and Forecast, By Type
9.2.10.5. Market Size and Forecast, By End User
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Market Size and Forecast, By Technology
9.3.3. Market Size and Forecast, By Product
9.3.4. Market Size and Forecast, By Application
9.3.5. Market Size and Forecast, By Type
9.3.6. Market Size and Forecast, By End User
9.3.7. Market Size and Forecast, By Country
9.3.8. Germany HLA Typing for Transplant Market
9.3.8.1. Market Size and Forecast, By Technology
9.3.8.2. Market Size and Forecast, By Product
9.3.8.3. Market Size and Forecast, By Application
9.3.8.4. Market Size and Forecast, By Type
9.3.8.5. Market Size and Forecast, By End User
9.3.9. France HLA Typing for Transplant Market
9.3.9.1. Market Size and Forecast, By Technology
9.3.9.2. Market Size and Forecast, By Product
9.3.9.3. Market Size and Forecast, By Application
9.3.9.4. Market Size and Forecast, By Type
9.3.9.5. Market Size and Forecast, By End User
9.3.10. UK HLA Typing for Transplant Market
9.3.10.1. Market Size and Forecast, By Technology
9.3.10.2. Market Size and Forecast, By Product
9.3.10.3. Market Size and Forecast, By Application
9.3.10.4. Market Size and Forecast, By Type
9.3.10.5. Market Size and Forecast, By End User
9.3.11. Italy HLA Typing for Transplant Market
9.3.11.1. Market Size and Forecast, By Technology
9.3.11.2. Market Size and Forecast, By Product
9.3.11.3. Market Size and Forecast, By Application
9.3.11.4. Market Size and Forecast, By Type
9.3.11.5. Market Size and Forecast, By End User
9.3.12. Spain HLA Typing for Transplant Market
9.3.12.1. Market Size and Forecast, By Technology
9.3.12.2. Market Size and Forecast, By Product
9.3.12.3. Market Size and Forecast, By Application
9.3.12.4. Market Size and Forecast, By Type
9.3.12.5. Market Size and Forecast, By End User
9.3.13. Rest Of Europe HLA Typing for Transplant Market
9.3.13.1. Market Size and Forecast, By Technology
9.3.13.2. Market Size and Forecast, By Product
9.3.13.3. Market Size and Forecast, By Application
9.3.13.4. Market Size and Forecast, By Type
9.3.13.5. Market Size and Forecast, By End User
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Market Size and Forecast, By Technology
9.4.3. Market Size and Forecast, By Product
9.4.4. Market Size and Forecast, By Application
9.4.5. Market Size and Forecast, By Type
9.4.6. Market Size and Forecast, By End User
9.4.7. Market Size and Forecast, By Country
9.4.8. Japan HLA Typing for Transplant Market
9.4.8.1. Market Size and Forecast, By Technology
9.4.8.2. Market Size and Forecast, By Product
9.4.8.3. Market Size and Forecast, By Application
9.4.8.4. Market Size and Forecast, By Type
9.4.8.5. Market Size and Forecast, By End User
9.4.9. China HLA Typing for Transplant Market
9.4.9.1. Market Size and Forecast, By Technology
9.4.9.2. Market Size and Forecast, By Product
9.4.9.3. Market Size and Forecast, By Application
9.4.9.4. Market Size and Forecast, By Type
9.4.9.5. Market Size and Forecast, By End User
9.4.10. Australia HLA Typing for Transplant Market
9.4.10.1. Market Size and Forecast, By Technology
9.4.10.2. Market Size and Forecast, By Product
9.4.10.3. Market Size and Forecast, By Application
9.4.10.4. Market Size and Forecast, By Type
9.4.10.5. Market Size and Forecast, By End User
9.4.11. India HLA Typing for Transplant Market
9.4.11.1. Market Size and Forecast, By Technology
9.4.11.2. Market Size and Forecast, By Product
9.4.11.3. Market Size and Forecast, By Application
9.4.11.4. Market Size and Forecast, By Type
9.4.11.5. Market Size and Forecast, By End User
9.4.12. South Korea HLA Typing for Transplant Market
9.4.12.1. Market Size and Forecast, By Technology
9.4.12.2. Market Size and Forecast, By Product
9.4.12.3. Market Size and Forecast, By Application
9.4.12.4. Market Size and Forecast, By Type
9.4.12.5. Market Size and Forecast, By End User
9.4.13. Rest of Asia-Pacific HLA Typing for Transplant Market
9.4.13.1. Market Size and Forecast, By Technology
9.4.13.2. Market Size and Forecast, By Product
9.4.13.3. Market Size and Forecast, By Application
9.4.13.4. Market Size and Forecast, By Type
9.4.13.5. Market Size and Forecast, By End User
9.5. LAMEA
9.5.1. Key Market Trends and Opportunities
9.5.2. Market Size and Forecast, By Technology
9.5.3. Market Size and Forecast, By Product
9.5.4. Market Size and Forecast, By Application
9.5.5. Market Size and Forecast, By Type
9.5.6. Market Size and Forecast, By End User
9.5.7. Market Size and Forecast, By Country
9.5.8. Brazil HLA Typing for Transplant Market
9.5.8.1. Market Size and Forecast, By Technology
9.5.8.2. Market Size and Forecast, By Product
9.5.8.3. Market Size and Forecast, By Application
9.5.8.4. Market Size and Forecast, By Type
9.5.8.5. Market Size and Forecast, By End User
9.5.9. Saudi Arabia HLA Typing for Transplant Market
9.5.9.1. Market Size and Forecast, By Technology
9.5.9.2. Market Size and Forecast, By Product
9.5.9.3. Market Size and Forecast, By Application
9.5.9.4. Market Size and Forecast, By Type
9.5.9.5. Market Size and Forecast, By End User
9.5.10. South Africa HLA Typing for Transplant Market
9.5.10.1. Market Size and Forecast, By Technology
9.5.10.2. Market Size and Forecast, By Product
9.5.10.3. Market Size and Forecast, By Application
9.5.10.4. Market Size and Forecast, By Type
9.5.10.5. Market Size and Forecast, By End User
9.5.11. Rest of LAMEA HLA Typing for Transplant Market
9.5.11.1. Market Size and Forecast, By Technology
9.5.11.2. Market Size and Forecast, By Product
9.5.11.3. Market Size and Forecast, By Application
9.5.11.4. Market Size and Forecast, By Type
9.5.11.5. Market Size and Forecast, By End User
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top Winning Strategies
10.3. Product Mapping Of Top 10 Player
10.4. Competitive Dashboard
10.5. Competitive Heatmap
10.6. Top Player Positioning, 2023
CHAPTER 11: COMPANY PROFILES
11.1. Luminex Corporation
11.1.1. Company Overview
11.1.2. Key Executives
11.1.3. Company Snapshot
11.1.4. Operating Business Segments
11.1.5. Product Portfolio
11.1.6. Business Performance
11.1.7. Key Strategic Moves and Developments
11.2. Pacific Biosciences Of California, Inc
11.2.1. Company Overview
11.2.2. Key Executives
11.2.3. Company Snapshot
11.2.4. Operating Business Segments
11.2.5. Product Portfolio
11.2.6. Business Performance
11.2.7. Key Strategic Moves and Developments
11.3. Abbott Laboratories
11.3.1. Company Overview
11.3.2. Key Executives
11.3.3. Company Snapshot
11.3.4. Operating Business Segments
11.3.5. Product Portfolio
11.3.6. Business Performance
11.3.7. Key Strategic Moves and Developments
11.4. Bio-Rad Laboratories
11.4.1. Company Overview
11.4.2. Key Executives
11.4.3. Company Snapshot
11.4.4. Operating Business Segments
11.4.5. Product Portfolio
11.4.6. Business Performance
11.4.7. Key Strategic Moves and Developments
11.5. BioReference Laboratories
11.5.1. Company Overview
11.5.2. Key Executives
11.5.3. Company Snapshot
11.5.4. Operating Business Segments
11.5.5. Product Portfolio
11.5.6. Business Performance
11.5.7. Key Strategic Moves and Developments
11.6. Qiagen N.V
11.6.1. Company Overview
11.6.2. Key Executives
11.6.3. Company Snapshot
11.6.4. Operating Business Segments
11.6.5. Product Portfolio
11.6.6. Business Performance
11.6.7. Key Strategic Moves and Developments
11.7. F. Hoffmann-La Roche Ltd.
11.7.1. Company Overview
11.7.2. Key Executives
11.7.3. Company Snapshot
11.7.4. Operating Business Segments
11.7.5. Product Portfolio
11.7.6. Business Performance
11.7.7. Key Strategic Moves and Developments
11.8. Illumina Inc.
11.8.1. Company Overview
11.8.2. Key Executives
11.8.3. Company Snapshot
11.8.4. Operating Business Segments
11.8.5. Product Portfolio
11.8.6. Business Performance
11.8.7. Key Strategic Moves and Developments
11.9. Fujirebio
11.9.1. Company Overview
11.9.2. Key Executives
11.9.3. Company Snapshot
11.9.4. Operating Business Segments
11.9.5. Product Portfolio
11.9.6. Business Performance
11.9.7. Key Strategic Moves and Developments
11.10. BAG Diagnostic GmbH
11.10.1. Company Overview
11.10.2. Key Executives
11.10.3. Company Snapshot
11.10.4. Operating Business Segments
11.10.5. Product Portfolio
11.10.6. Business Performance
11.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 2. Hla Typing for Transplant Market for Molecular Assay, by Region, 2024 - 2033 ($Billion)
Table 3. Hla Typing for Transplant Market for Non-Molecular Assay, by Region, 2024 - 2033 ($Billion)
Table 4. Global Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 5. Hla Typing for Transplant Market for Instruments, by Region, 2024 - 2033 ($Billion)
Table 6. Hla Typing for Transplant Market for Reagents Consumables, by Region, 2024 - 2033 ($Billion)
Table 7. Hla Typing for Transplant Market for Software Services, by Region, 2024 - 2033 ($Billion)
Table 8. Global Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 9. Hla Typing for Transplant Market for Diagnostic, by Region, 2024 - 2033 ($Billion)
Table 10. Hla Typing for Transplant Market for Research, by Region, 2024 - 2033 ($Billion)
Table 11. Global Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 12. Hla Typing for Transplant Market for Organ Transplant, by Region, 2024 - 2033 ($Billion)
Table 13. Hla Typing for Transplant Market for Tissue, by Region, 2024 - 2033 ($Billion)
Table 14. Global Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 15. Hla Typing for Transplant Market for Independent Reference Laboratories, by Region, 2024 - 2033 ($Billion)
Table 16. Hla Typing for Transplant Market for Hospital Transplant Center, by Region, 2024 - 2033 ($Billion)
Table 17. Hla Typing for Transplant Market for Other, by Region, 2024 - 2033 ($Billion)
Table 18. Hla Typing for Transplant Market, by Region, 2024 - 2033 ($Billion)
Table 19. North America Hla Typing for Transplant Market, by Country, 2024 - 2033 ($Billion)
Table 20. North America Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 21. North America Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 22. North America Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 23. North America Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 24. North America Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 25. U.S. Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 26. U.S. Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 27. U.S. Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 28. U.S. Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 29. U.S. Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 30. Canada Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 31. Canada Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 32. Canada Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 33. Canada Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 34. Canada Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 35. Mexico Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 36. Mexico Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 37. Mexico Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 38. Mexico Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 39. Mexico Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 40. Europe Hla Typing for Transplant Market, by Country, 2024 - 2033 ($Billion)
Table 41. Europe Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 42. Europe Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 43. Europe Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 44. Europe Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 45. Europe Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 46. Germany Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 47. Germany Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 48. Germany Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 49. Germany Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 50. Germany Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 51. France Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 52. France Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 53. France Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 54. France Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 55. France Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 56. UK Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 57. UK Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 58. UK Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 59. UK Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 60. UK Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 61. Italy Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 62. Italy Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 63. Italy Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 64. Italy Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 65. Italy Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 66. Spain Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 67. Spain Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 68. Spain Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 69. Spain Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 70. Spain Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 71. Rest of Europe Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 72. Rest of Europe Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 73. Rest of Europe Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 74. Rest of Europe Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 75. Rest of Europe Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 76. Asia-Pacific Hla Typing for Transplant Market, by Country, 2024 - 2033 ($Billion)
Table 77. Asia-Pacific Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 78. Asia-Pacific Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 79. Asia-Pacific Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 80. Asia-Pacific Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 81. Asia-Pacific Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 82. Japan Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 83. Japan Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 84. Japan Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 85. Japan Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 86. Japan Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 87. China Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 88. China Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 89. China Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 90. China Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 91. China Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 92. Australia Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 93. Australia Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 94. Australia Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 95. Australia Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 96. Australia Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 97. India Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 98. India Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 99. India Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 100. India Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 101. India Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 102. South Korea Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 103. South Korea Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 104. South Korea Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 105. South Korea Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 106. South Korea Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 107. Rest of Asia-Pacific Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 108. Rest of Asia-Pacific Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 109. Rest of Asia-Pacific Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 110. Rest of Asia-Pacific Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 111. Rest of Asia-Pacific Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 112. LAMEA Hla Typing for Transplant Market, by Country, 2024 - 2033 ($Billion)
Table 113. LAMEA Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 114. LAMEA Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 115. LAMEA Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 116. LAMEA Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 117. LAMEA Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 118. Brazil Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 119. Brazil Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 120. Brazil Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 121. Brazil Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 122. Brazil Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 123. Saudi Arabia Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 124. Saudi Arabia Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 125. Saudi Arabia Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 126. Saudi Arabia Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 127. Saudi Arabia Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 128. South Africa Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 129. South Africa Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 130. South Africa Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 131. South Africa Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 132. South Africa Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 133. Rest of LAMEA Hla Typing for Transplant Market, by Technology, 2024 - 2033 ($Billion)
Table 134. Rest of LAMEA Hla Typing for Transplant Market, by Product, 2024 - 2033 ($Billion)
Table 135. Rest of LAMEA Hla Typing for Transplant Market, by Application, 2024 - 2033 ($Billion)
Table 136. Rest of LAMEA Hla Typing for Transplant Market, by Type, 2024 - 2033 ($Billion)
Table 137. Rest of LAMEA Hla Typing for Transplant Market, by End-user, 2024 - 2033 ($Billion)
Table 138. Luminex Corporation: Key Executives
Table 139. Luminex Corporation: Company Snapshot
Table 140. Luminex Corporation: Operating Segments
Table 141. Luminex Corporation: Product Portfolio
Table 142. Luminex Corporation: Key Strategic Moves and Developments
Table 143. Pacific Biosciences of California, Inc.: Key Executives
Table 144. Pacific Biosciences of California, Inc.: Company Snapshot
Table 145. Pacific Biosciences of California, Inc.: Operating Segments
Table 146. Pacific Biosciences of California, Inc.: Product Portfolio
Table 147. Pacific Biosciences of California, Inc.: Key Strategic Moves and Developments
Table 148. Abbott Laboratories: Key Executives
Table 149. Abbott Laboratories: Company Snapshot
Table 150. Abbott Laboratories: Operating Segments
Table 151. Abbott Laboratories: Product Portfolio
Table 152. Abbott Laboratories: Key Strategic Moves and Developments
Table 153. Bio-Rad Laboratories: Key Executives
Table 154. Bio-Rad Laboratories: Company Snapshot
Table 155. Bio-Rad Laboratories: Operating Segments
Table 156. Bio-Rad Laboratories: Product Portfolio
Table 157. Bio-Rad Laboratories: Key Strategic Moves and Developments
Table 158. Bioreference Laboratories: Key Executives
Table 159. Bioreference Laboratories: Company Snapshot
Table 160. Bioreference Laboratories: Operating Segments
Table 161. Bioreference Laboratories: Product Portfolio
Table 162. Bioreference Laboratories: Key Strategic Moves and Developments
Table 163. Qiagen N.V: Key Executives
Table 164. Qiagen N.V: Company Snapshot
Table 165. Qiagen N.V: Operating Segments
Table 166. Qiagen N.V: Product Portfolio
Table 167. Qiagen N.V: Key Strategic Moves and Developments
Table 168. F. Hoffmann-La Roche Ltd.: Key Executives
Table 169. F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 170. F. Hoffmann-La Roche Ltd.: Operating Segments
Table 171. F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 172. F. Hoffmann-La Roche Ltd.: Key Strategic Moves and Developments
Table 173. Illumina Inc.: Key Executives
Table 174. Illumina Inc.: Company Snapshot
Table 175. Illumina Inc.: Operating Segments
Table 176. Illumina Inc.: Product Portfolio
Table 177. Illumina Inc.: Key Strategic Moves and Developments
Table 178. Fujirebio: Key Executives
Table 179. Fujirebio: Company Snapshot
Table 180. Fujirebio: Operating Segments
Table 181. Fujirebio: Product Portfolio
Table 182. Fujirebio: Key Strategic Moves and Developments
Table 183. Bag Diagnostic GmbH: Key Executives
Table 184. Bag Diagnostic GmbH: Company Snapshot
Table 185. Bag Diagnostic GmbH: Operating Segments
Table 186. Bag Diagnostic GmbH: Product Portfolio
Table 187. Bag Diagnostic GmbH: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Hla Typing for Transplant Market, 2024 - 2033
Figure 2. Segmentation of Hla Typing for Transplant Market, 2024 - 2033
Figure 3. Top Investment Pocket in Hla Typing for Transplant Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalhla Typing for Transplant Market
Figure 10. Global Hla Typing for Transplant Market Segmentation, by Technology
Figure 11. Hla Typing for Transplant Market for Molecular Assay, by Country, 2024 - 2033 ($Billion)
Figure 12. Hla Typing for Transplant Market for Non-Molecular Assay, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Hla Typing for Transplant Market Segmentation, by Product
Figure 14. Hla Typing for Transplant Market for Instruments, by Country, 2024 - 2033 ($Billion)
Figure 15. Hla Typing for Transplant Market for Reagents Consumables, by Country, 2024 - 2033 ($Billion)
Figure 16. Hla Typing for Transplant Market for Software Services, by Country, 2024 - 2033 ($Billion)
Figure 17. Global Hla Typing for Transplant Market Segmentation, by Application
Figure 18. Hla Typing for Transplant Market for Diagnostic, by Country, 2024 - 2033 ($Billion)
Figure 19. Hla Typing for Transplant Market for Research, by Country, 2024 - 2033 ($Billion)
Figure 20. Global Hla Typing for Transplant Market Segmentation, by Type
Figure 21. Hla Typing for Transplant Market for Organ Transplant, by Country, 2024 - 2033 ($Billion)
Figure 22. Hla Typing for Transplant Market for Tissue, by Country, 2024 - 2033 ($Billion)
Figure 23. Global Hla Typing for Transplant Market Segmentation, by End-user
Figure 24. Hla Typing for Transplant Market for Independent Reference Laboratories, by Country, 2024 - 2033 ($Billion)
Figure 25. Hla Typing for Transplant Market for Hospital Transplant Center, by Country, 2024 - 2033 ($Billion)
Figure 26. Hla Typing for Transplant Market for Other, by Country, 2024 - 2033 ($Billion)
Figure 27. Top Winning Strategies, by Year, 2021-2023*
Figure 28. Top Winning Strategies, by Development, 2021-2023*
Figure 29. Top Winning Strategies, by Company, 2021-2023*
Figure 30. Product Mapping of Top 10 Players
Figure 31. Competitive Dashboard
Figure 32. Competitive Heatmap: Hla Typing for Transplant Market
Figure 33. Top Player Positioning, 2023
Figure 34. Luminex Corporation: Net Sales, 2021-2023 ($Billion)
Figure 35. Luminex Corporation: Revenue Share, by Segment, 2023 (%)
Figure 36. Luminex Corporation: Revenue Share, by Region, 2023 (%)
Figure 37. Pacific Biosciences of California, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 38. Pacific Biosciences of California, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 39. Pacific Biosciences of California, Inc.: Revenue Share, by Region, 2023 (%)
Figure 40. Abbott Laboratories: Net Sales, 2021-2023 ($Billion)
Figure 41. Abbott Laboratories: Revenue Share, by Segment, 2023 (%)
Figure 42. Abbott Laboratories: Revenue Share, by Region, 2023 (%)
Figure 43. Bio-Rad Laboratories: Net Sales, 2021-2023 ($Billion)
Figure 44. Bio-Rad Laboratories: Revenue Share, by Segment, 2023 (%)
Figure 45. Bio-Rad Laboratories: Revenue Share, by Region, 2023 (%)
Figure 46. Bioreference Laboratories: Net Sales, 2021-2023 ($Billion)
Figure 47. Bioreference Laboratories: Revenue Share, by Segment, 2023 (%)
Figure 48. Bioreference Laboratories: Revenue Share, by Region, 2023 (%)
Figure 49. Qiagen N.V: Net Sales, 2021-2023 ($Billion)
Figure 50. Qiagen N.V: Revenue Share, by Segment, 2023 (%)
Figure 51. Qiagen N.V: Revenue Share, by Region, 2023 (%)
Figure 52. F. Hoffmann-La Roche Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 53. F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 54. F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2023 (%)
Figure 55. Illumina Inc.: Net Sales, 2021-2023 ($Billion)
Figure 56. Illumina Inc.: Revenue Share, by Segment, 2023 (%)
Figure 57. Illumina Inc.: Revenue Share, by Region, 2023 (%)
Figure 58. Fujirebio: Net Sales, 2021-2023 ($Billion)
Figure 59. Fujirebio: Revenue Share, by Segment, 2023 (%)
Figure 60. Fujirebio: Revenue Share, by Region, 2023 (%)
Figure 61. Bag Diagnostic GmbH: Net Sales, 2021-2023 ($Billion)
Figure 62. Bag Diagnostic GmbH: Revenue Share, by Segment, 2023 (%)
Figure 63. Bag Diagnostic GmbH: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • Luminex Corporation
  • Pacific Biosciences of California, Inc
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • BioReference Laboratories
  • Qiagen N.V
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Fujirebio
  • BAG Diagnostic GmbH

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information